TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage SCLC: Results From TROPiCS-03.

Afshin Dowlati et al.PubMed ↗Publisher ↗

No numbers read from the abstract.